top of page

Our technology

Liposome carries

Liposomal delivery of CRISPR

While the CRISPR editing tool has revolutionized biomedical applications, delivery remains a critical challenge for its practical use. At EosGene, we have successfully developed innovative liposome delivery technology to overcome this hurdle, ensuring that CRISPR therapy is not only safe but also highly effective in treating the disease.

​

  • Our liposomes are made from clinically approved lipids, ensuring cost effectiveness and scalability.

  • They are broadly applicable, to gene therapy and for the delivery of drugs and vaccines.

  • Their unique feature is spatial and temporal control of gene delivery.  

  • Light (or X rays) cause generation of oxygen radicals in the liposome membrane  releasing therapeutic genes inside of cells. 

small cover image of NCOMMS.jpg

Our publications

Published in Nature Communications

https://www.nature.com/articles/s41467-018-05118-3 .

Published in ACS Applied Materials and Interfaces

https://pubs.acs.org/doi/10.1021/acsami.0c16380

​

Liposomal delivery of CRISPR

Contact Us

 EosGene Pty Ltd

 ABN: 59 660 440 826

042 024 6004

© 2023 by EosGene Powered and secured by Wix

Thanks for submitting!

bottom of page